VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,247,764 | +528.1% | 880,231 | +1544.2% | 0.01% | +800.0% |
| Q2 2023 | $1,313,214 | -16.1% | 53,535 | -20.5% | 0.00% | -50.0% |
| Q1 2023 | $1,566,071 | +37.5% | 67,300 | +49.6% | 0.00% | +100.0% |
| Q4 2022 | $1,138,823 | +298.2% | 44,995 | +203.7% | 0.00% | – |
| Q3 2022 | $286,000 | +30.6% | 14,818 | +72.5% | 0.00% | – |
| Q2 2022 | $219,000 | -83.7% | 8,588 | -83.6% | 0.00% | -100.0% |
| Q1 2022 | $1,343,000 | -77.8% | 52,230 | -63.9% | 0.00% | -80.0% |
| Q4 2021 | $6,063,000 | -16.6% | 144,802 | -13.4% | 0.01% | -28.6% |
| Q3 2021 | $7,274,000 | -29.8% | 167,126 | -23.8% | 0.01% | -22.2% |
| Q2 2021 | $10,365,000 | +73.9% | 219,228 | +88.5% | 0.01% | +50.0% |
| Q1 2021 | $5,962,000 | +931.5% | 116,292 | +439.1% | 0.01% | +500.0% |
| Q4 2020 | $578,000 | – | 21,571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |